-

SHAREHOLDER ALERT: Robbins LLP Informs Shareholders of Class Action Against Gatos Silver, Inc. (GATO)

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Gatos Silver, Inc. (NYSE: GATO) (a) common stock pursuant to the Company's October 2020 initial public offering ("IPO") and/or (b) securities between October 28, 2020 and January 25, 2022. Gatos Silver engages in the exploration, development, and production of precious metals.

If you would like more information about our investigation of Gatos Silver, Inc.'s misconduct, click here.

What is this Case About: Gatos Silver, Inc. (GATO) Announces Errors in Mineral Resource and Reserve Estimates in its 2020 Technical Report

According to the complaint, defendants made false and misleading statements in the Registration Statement in support of the IPO and during the class period. Specifically, defendants failed to disclose to investors: (1) that the technical report for Gatos Silver's primary mine contained certain errors, and (2) the mineral reserves had been overstated by as much as 50%.

On January 25, 2022, Gatos Silver provided a resource and reserve update for the Los Gatos Joint Venture, concluding "that there were errors in the technical report entitled 'Los Gatos Project, Chihuahua, Mexico' with an effective date of July 1, 2020 (the ‘2020 Technical Report'), as well as indications that there is an overestimation in the existing resource model." Therefore, "[o]n a preliminary basis, the Company estimates a potential reduction of the metal content of CLG's mineral reserve ranging from 30% to 50% of the metal content remaining after depletion" and advised that "the mineral resource and reserve estimates in the 2020 Technical Report should not be relied upon." Following this news, Gatos Silver stock fell by 69% to close at $3.17 per share on January 26, 2022. By the commencement of the lawsuit, Gatos Silver shares were still down significantly from its $7.00 per share IPO price.

Next Steps: If you acquired shares of Gatos Silver, Inc. (GATO) pursuant to the Company's October 2020 IPO or between October 28, 2020 and January 25, 2022, you have until April 25, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Gatos Silver, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:GATO

Release Summary
Gatos Silver, Inc. (GATO) Announces Errors in Mineral Resource and Reserve Estimates in its 2020 Technical Report
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom